Screener
Rigel Pharmaceuticals RIGL Free cash flow
Discontinued — last reported Q4 '22
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Rigel Pharmaceuticals’s reported figures.
The source filing: Rigel Pharmaceuticals’s 10-K, filed March 4, 2025. Open the filing →
- Filed
- Mar 4, 2025
- Fiscal year
- FY2024
- Accession
- 0001558370-25-002169
FAQ
- What is Rigel Pharmaceuticals's free cash flow?
- Rigel Pharmaceuticals (RIGL) reported free cash flow of -$21.98M in Q4 2022.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Rigel Pharmaceuticals's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude